Daniela Dr. Brenner

Daniela Dr. Brenner has extensive work experience in the pharmaceutical industry. Daniela has worked in various roles and companies throughout their career. In their most recent role, starting in 2020, they served as the Commercial Director for Germany at Amicus Therapeutics. Prior to that, from 2019 to 2020, they were the Sales Director for Germany at GMP Orphan Deutschland GmbH. From 2018 to 2019, they worked as a Consultant for Sales & Marketing Projects at LMV. Before that, from 2016 to 2018, they held the position of Director of Sales for Rare Diseases in Germany at Raptor Pharmaceuticals GmbH/Horizon Pharma Germany GmbH. From 2014 to 2016, they were the Manager of Sales for Endocrinology/Oncology in Germany at Ipsen. Daniela also gained valuable experience at Genzyme sanofi, where they held multiple roles including Head of Rare Diseases Business Unit Austria, Key Account Manager for Lysosomal Storage Disorders, and Scientific Consultant for Lysosomal Storage Disorders. Additionally, they have worked at Merz Pharmaceuticals, Berlin-Chemie AG, and pharmexx International in various roles related to medical marketing, scientific communication, and pharmaceutical consulting.

Daniela Dr. Brenner obtained their Diplom degree in Biologie/biologische Wissenschaften, allgemein from the Karlsruhe Institute of Technology (KIT) in 1996. Daniela then pursued a further diploma in the same field at the Max-Planck-Institut für Physiologische und Klinische Forschung in 1997. From 1998 to 2002, they completed their Promotion in Biologie/biologische Wissenschaften, allgemein at the Max-Planck-Institut für Physiologische und Klinische Forschung.